TNF and IL-17 pathways play a synergistic role in IDD progression, mainly by promoting the release of inflammatory mediators, the apoptosis of NP cells, and the degradation of ECM [57–59]. The gene discussed is TNF; the disease is intervertebral disk degenerative disorder.